Medicines use review service in community pharmacies in Spain: REVISA project
| Autor: | Francisco Jódar-Sánchez, Nuria García-Agua Soler, Javier Velasco-Martínez, Eugenia Gómez-Bermúdez, Antonio J. García Ruiz, Vicente J. Baixauli-Fernández, Sara Bellver-Beltrán |
|---|---|
| Přispěvatelé: | Sociedad Española de Farmacia Clínica, Familiar y Comunitaria, Ratiopharm, Teva Pharmaceutical Industries |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Referral Pharmaceutical Science Pharmacy Community Pharmacy Services Toxicology Pharmacists 03 medical and health sciences 0302 clinical medicine Professional Role Willingness to pay medicine Humans Pharmacology (medical) 030212 general & internal medicine Medicine use Pharmacology Service (business) Polypharmacy Pharmacies Community pharmacies business.industry 030503 health policy & services Infant Newborn Medicines use review Cross-Sectional Studies Adherence Spain Family medicine Structured interview Female 0305 other medical science business Research Article |
| Zdroj: | Digital.CSIC. Repositorio Institucional del CSIC instname International Journal of Clinical Pharmacy |
| DOI: | 10.1007/s11096-020-01158-2.pdf |
| Popis: | [Background] Community pharmacy services play an important role in controlling some factors related to medicine use and patients can benefit from these services to improve the adherence and knowledge of their medications, besides to reduce medicine-related problems. [Objective] The aim of the REVISA project is to carry out a study on preliminary implementation of the medicines use review service in Spanish community pharmacies. Setting Sixty-four community pharmacies from all regions of Spain. [Method] A preliminary implementation, cross-sectional multicentre study was conducted using a convenience sample of voluntary community pharmacies. A structured interview enabled to pharmacists to obtain a better understanding of patient’s medicines use. [Main outcome measure] Medicines use review-related time and cost, satisfaction and willingness to pay. [Results] A total of 495 patients were enrolled. The mean age of the patients was 66.1 years, with the majority females (56.4%) and a mean consumption of 5.7 medicines. A total of 2811 medicines were evaluated and 550 referral recommendations were made (29.8% to Primary Care). The mean time employed by the pharmacists in the medicines use review service was 52.8 min (medicines use review-related cost of €17.27). Most patients expressed a high level of satisfaction with this service (98.5%) and a willingness to pay for it (84%). [Conclusion] Medicines use review service in community pharmacies in Spain can be delivered, that it appears to be acceptable to patients and that most patients said they would be willing to pay for it. This service may offer an opportunity to promote inter-professional collaboration between pharmacists and general practitioners. The REVISA project presents independent research funded by SEFAC (Sociedad Española de Farmacia Familiar y Comunitaria), with the collaboration of TEVA and Ratiopharm. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|